UK Health Secretary Matt Hancock holds Government Press Conference on vaccine progress

The video discusses the UK's efforts in developing and procuring vaccines, highlighting the role of the Jenner Institute at Oxford University in repurposing previous research to quickly develop a coronavirus vaccine. It emphasizes global collaboration with partners like Pfizer and Biontech, leading to the UK being the first to authorize their vaccine. The Moderna vaccine is also mentioned as ready for use. The video concludes with a focus on the challenges of vaccine supply and the importance of developing future manufacturing capabilities.

What previous investments helped the UK quickly develop a coronavirus vaccine?

• Investment in Ebola and MERS vaccines

• Investment in flu vaccines

• Investment in polio vaccines

• Investment in malaria vaccines

Which international partners did the UK work with to authorize a COVID-19 vaccine?

• Pfizer and Biontech

• Moderna and AstraZeneca

• Johnson & Johnson and Novavax

• Sinovac and Sputnik V

Which vaccine was mentioned as being ready to bring onstream after authorization?

• Sinopharm

• AstraZeneca

• Moderna

• Johnson & Johnson

What is the current limiting factor in the vaccine distribution process?

• Vaccine demand

• Vaccine storage

• Vaccine supply

• Vaccine transportation

What is the UK planning to ensure for future vaccine needs?

• Import more vaccines

• Reduce vaccine prices

• Develop vaccine manufacturing capabilities

• Increase vaccine storage facilities